Literature DB >> 19705524

Tumour suppressors: Different roads to inactivation.

Sarah Seton-Rogers.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19705524     DOI： 10.1038/nrc2719

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  1 in total

1.  Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.

Authors:  Lauren T McGillicuddy; Jody A Fromm; Pablo E Hollstein; Sara Kubek; Rameen Beroukhim; Thomas De Raedt; Bryan W Johnson; Sybil M G Williams; Phioanh Nghiemphu; Linda M Liau; Tim F Cloughesy; Paul S Mischel; Annabel Parret; Jeanette Seiler; Gerd Moldenhauer; Klaus Scheffzek; Anat O Stemmer-Rachamimov; Charles L Sawyers; Cameron Brennan; Ludwine Messiaen; Ingo K Mellinghoff; Karen Cichowski
Journal:  Cancer Cell       Date:  2009-07-07       Impact factor: 31.743
  1 in total
  2 in total

1.  Chronic DLL4 blockade induces vascular neoplasms.

Authors:  Minhong Yan; Christopher A Callahan; Joseph C Beyer; Krishna P Allamneni; Gu Zhang; John Brady Ridgway; Kyle Niessen; Greg D Plowman
Journal:  Nature       Date:  2010-02-11       Impact factor: 49.962

2.  Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma.

Authors:  Lilly Y W Bourguignon; Gabriel Wong; Marisa Shiina
Journal:  J Biol Chem       Date:  2016-03-21       Impact factor: 5.157
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.